Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postterm pregnancy after previous cesarean section.

S Yeh, X Huang, J P Phelan

    The Journal of Reproductive Medicine
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.

    Oncogene·2016
    Same author

    Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models.

    BMC cancer·2016
    Same author

    Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals.

    Oncogene·2016
    Same author

    Predicting carotid artery disease and plaque instability from cell-derived microparticles.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2014
    Same author

    Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.

    Cell death & disease·2013
    Same author

    Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.

    Oncogene·2013
    Same journal

    Elective Procedures in Obstetrics and Gynecology During the COVID-19 Pandemic.

    The Journal of reproductive medicine·2022
    Same journal

    Choriocarcinoma in Situ in a Partial Hydatidiform Mole A: Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Isolated Recurrent Hematotrachelos After Abdominal Myomectomy A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Live Birth from Electively Cryopreserved Oocytes: A Feasible Option for Couples Opposed to Embryo Cryopreservation A Case Report.

    The Journal of reproductive medicine·2018
    Same journal

    Prevalence and Risk Factors of Ejaculation Failure on the Day of Operation Among Chinese Males Undergoing Assisted Reproductive Technique Treatments.

    The Journal of reproductive medicine·2018
    Same journal

    Efficacy and Safety of Perioperative Use of Epinephrine for Laparoscopic Myomectomy in Infertile Women with Symptomatic Solitary Intramural Uterine Fibroids A Randomized Clinical Trial.

    The Journal of reproductive medicine·2018
    See all related articles

    Women with postterm pregnancy and prior cesarean delivery can safely attempt a trial of labor (TOL). Vaginal birth after cesarean (VBAC) in postterm pregnancies did not increase risks and reduced maternal morbidity compared to repeat cesarean.

    Area of Science:

    • Obstetrics and Gynecology
    • Maternal-Fetal Medicine
    • Reproductive Health

    Background:

    • Postterm pregnancy and previous cesarean delivery (C/S) present complex management decisions.
    • Current protocols often favor repeat C/S, potentially increasing maternal morbidity.

    Purpose of the Study:

    • To evaluate the safety and outcomes of trial of labor (TOL) in patients with postterm pregnancy and prior C/S.
    • To develop an evidence-based management scheme for this patient population.

    Main Methods:

    • Retrospective analysis of 112 patients with postterm pregnancy and previous C/S.
    • Patients were managed in a dedicated postdates clinic following a standardized protocol.
    • Outcomes assessed included vaginal delivery rates, maternal morbidity, and perinatal outcomes.

    Related Experiment Videos

    Main Results:

    • 69.6% of patients attempted a trial of labor (TOL), with a 73.1% vaginal delivery success rate.
    • Vaginal birth after cesarean (VBAC) was successful in 42.2% of patients with prior C/S for cephalopelvic disproportion.
    • Maternal morbidity (postpartum fever, transfusion) was significantly higher in patients undergoing repeat C/S compared to vaginal delivery.
    • Postdates pregnancy did not increase the risk of uterine rupture during TOL.

    Conclusions:

    • Postterm pregnancy should not be an absolute contraindication to a trial of labor (TOL) in women with previous cesarean delivery (C/S).
    • Trial of labor (TOL) in this cohort is associated with favorable vaginal birth rates and reduced maternal morbidity.
    • Further research into optimizing TOL protocols for postterm pregnancies with prior C/S is warranted.